TFR-20338-11650
3 vaccinations
7 coded responses
38 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 985 / WA
- Registered
- 2021-08-10
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
GZ2-29184-97867
Child or adolescent in my care · Female · 2022-08-04
Timeline
-
2021-08-10
Registered in v-safe
-
2021-08-10
Dose 1 — Pfizer-BioNTech
-
2021-08-10
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-08-11
Survey response — days 1–6 daily, dose 1MedDRA: Heart rate increased — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessFree text: Increased heart rate (mild)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-08-13
-
2021-08-14
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness, Heart rate increased — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Increased heart rate, lightheaded at times (may be dehydrated)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-16
- 2021-08-17
- 2021-08-24
-
2021-08-31
Dose 2 — Pfizer-BioNTech
- 2021-08-31
-
2021-09-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-09-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-09-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-09-05
- 2021-09-06
- 2021-09-07
- 2021-09-14
- 2021-09-22
-
2021-09-29
Survey response — day 28, dose 2MedDRA: Diarrhoea — Feeling: GoodFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — day 35, dose 2MedDRA: Constipation, Diarrhoea, Gastrointestinal disorder — Feeling: FairFree text: GI symptoms (diarrhea, constipation)MedDRA releases: 2024-11 · check-in free text available
- 2021-10-12
- 2021-11-30
-
2022-02-03
Dose 3 — Pfizer-BioNTech
-
2022-02-03
Health check-in — day 0, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-02-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
- 2022-02-06
- 2022-02-07
- 2022-02-08
- 2022-02-09
- 2022-02-10
-
2022-02-17
Survey response — day 14, dose 3MedDRA: Heavy menstrual bleeding, Menstruation irregular, Paranasal sinus discomfort — Feeling: Good · Be unable to work or attend schoolFree text: Early and heavy period; irritated sinusMedDRA releases: 2024-11 · check-in free text available
-
2022-02-24
Survey response — day 21, dose 3MedDRA: Heavy menstrual bleeding, Menstruation irregular, Oropharyngeal pain — Feeling: Good · Be unable to work or attend schoolFree text: Mild sore throat; period unusually heavy and earlyMedDRA releases: 2024-11 · check-in free text available
- 2022-03-03
- 2022-03-10
- 2022-03-17
- 2022-05-05
- 2022-08-04
-
2023-02-04
Survey response — 12 months, dose 3MedDRA: Abortion spontaneous — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-10 | Pfizer-BioNTech | No |
| 2 | 2021-08-31 | Pfizer-BioNTech | No |
| 3 | 2022-02-03 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Increased heart rate (mild)
Systemic reaction (other): Increased heart rate, lightheaded at times (may be dehydrated)
Release 9 — day 28, dose 2
Symptoms: Diarrhea
Release 10 — day 35, dose 2
Symptoms: GI symptoms (diarrhea, constipation)
Release 11 — day 14, dose 3
Symptoms: Early and heavy period; irritated sinus
Release 11 — day 21, dose 3
Symptoms: Mild sore throat; period unusually heavy and early
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Constipation | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SRO | Dizziness | ✓ | · | ✓ |
| SRO | Heart rate increased | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release